The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
141 - Can a pharmaceutical company have an SMS text message medication reminder sign-up on a DIN-protected website where patients can sign up for a daily SMS reminder to take their medication?
-
Yes, a SMS reminder to take the medication is acceptable when a patient signs-up to participate in such program on a DIN protected patient website. Note that this site would require PAAB approval. As part of the approval process, we would require to review the SMS message wording. There should be a mechanism to ensure that the person receiving the SMS is still on the product (i.e. he/she is still a "patient"). For example, simple instructions on how to discontinue SMS reminders should be provided.
